Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients

Purpose: To evaluate effectiveness and safety of cataract surgery pharmacological support (which include 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) in glaucoma patients. Patients and Methods: Standard ophthal...

Full description

Bibliographic Details
Main Authors: S. V. Yanchenko, A. V. Malyshev, S. N. Sakhnov, G. Yu. Karapetov
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2018-10-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/697
id doaj-b95fb5d31fef4dd399bd9a46da85bb3c
record_format Article
spelling doaj-b95fb5d31fef4dd399bd9a46da85bb3c2021-07-29T08:55:26ZrusOphthalmology Publishing GroupOftalʹmologiâ 1816-50952018-10-0115333033810.18008/1816-5095-2018-3-330-338460Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma PatientsS. V. Yanchenko0A. V. Malyshev1S. N. Sakhnov2G. Yu. Karapetov3Kuban State Medical University; Scientific Research Institution — S.V. Ochapovsky Regional Clinic Hospital No. 1Kuban State Medical University; Scientific Research Institution — S.V. Ochapovsky Regional Clinic Hospital No. 1Kuban State Medical University; The Krasnodar branch IRTC “Eye Microsurgery” named after Acad. S.N. Fyodorov KrasnykhScientific Research Institution — S.V. Ochapovsky Regional Clinic Hospital No. 1Purpose: To evaluate effectiveness and safety of cataract surgery pharmacological support (which include 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) in glaucoma patients. Patients and Methods: Standard ophthalmological examination, subjective discomfort level evaluation, tear film break up time, tear meniscus height measurement, index of xerosis, evaluation and ocular surface condition photoregistration were performed in 40 II «A» primary open-angle glaucoma patients, receiving hypotensive therapy, before and after phacoemulsification (Ph). All patients in the postoperative period received instillations: 0.5 % levofloxacin (4 times a day, 7 days), 0.1 % dexamethasone (3 times a day, 7 days), 0.09 % bromfenac (once a day, 30 days) and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination (3 times a day, 30 days). Control points were: examination before Ph, on 1, 7 and 30 days after Ph. Results: None cases of infectious or inflammatory surgery complications were recorded. The SD level was significantly increased on the 1 and 7 days after Ph, by the 30 day the SD level was significantly decreased, compared with a state on the 1 and 7 days. On the 1, 7, 30 days after Ph TFBUT significantly decreased. By the 30 day after Ph the TFBUT was significantly increased in compare with 1 and 7 days after operation. TMH changes after Ph had multidirectional character and in general were not significant throughout the observation, with a tendency to increase on the 1 and 30 days after surgery and to decrease on the 7th day. IX dynamics in compare with a state before Ph was not significant in all control points with a tendency to its increase on the 1 and 7 days after operation and to decrease on the 30th day. In general, pharmacological support of Ph was assessed by all patients as comfortable, there was no intolerance. Conclusion: The cataract surgery pharmacological support in glaucoma patients (including 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) showed: high efficiency (in prevention of infectious and inflammatory complications); safety by influence on the ocular surface; comfort of use.https://www.ophthalmojournal.com/opht/article/view/697cataract surgeryglaucomapharmacological supportocular surface0.09 % bromfenac
collection DOAJ
language Russian
format Article
sources DOAJ
author S. V. Yanchenko
A. V. Malyshev
S. N. Sakhnov
G. Yu. Karapetov
spellingShingle S. V. Yanchenko
A. V. Malyshev
S. N. Sakhnov
G. Yu. Karapetov
Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients
Oftalʹmologiâ
cataract surgery
glaucoma
pharmacological support
ocular surface
0.09 % bromfenac
author_facet S. V. Yanchenko
A. V. Malyshev
S. N. Sakhnov
G. Yu. Karapetov
author_sort S. V. Yanchenko
title Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients
title_short Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients
title_full Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients
title_fullStr Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients
title_full_unstemmed Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients
title_sort effectiveness and safety of cataract surgery pharmacological support in glaucoma patients
publisher Ophthalmology Publishing Group
series Oftalʹmologiâ
issn 1816-5095
publishDate 2018-10-01
description Purpose: To evaluate effectiveness and safety of cataract surgery pharmacological support (which include 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) in glaucoma patients. Patients and Methods: Standard ophthalmological examination, subjective discomfort level evaluation, tear film break up time, tear meniscus height measurement, index of xerosis, evaluation and ocular surface condition photoregistration were performed in 40 II «A» primary open-angle glaucoma patients, receiving hypotensive therapy, before and after phacoemulsification (Ph). All patients in the postoperative period received instillations: 0.5 % levofloxacin (4 times a day, 7 days), 0.1 % dexamethasone (3 times a day, 7 days), 0.09 % bromfenac (once a day, 30 days) and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination (3 times a day, 30 days). Control points were: examination before Ph, on 1, 7 and 30 days after Ph. Results: None cases of infectious or inflammatory surgery complications were recorded. The SD level was significantly increased on the 1 and 7 days after Ph, by the 30 day the SD level was significantly decreased, compared with a state on the 1 and 7 days. On the 1, 7, 30 days after Ph TFBUT significantly decreased. By the 30 day after Ph the TFBUT was significantly increased in compare with 1 and 7 days after operation. TMH changes after Ph had multidirectional character and in general were not significant throughout the observation, with a tendency to increase on the 1 and 30 days after surgery and to decrease on the 7th day. IX dynamics in compare with a state before Ph was not significant in all control points with a tendency to its increase on the 1 and 7 days after operation and to decrease on the 30th day. In general, pharmacological support of Ph was assessed by all patients as comfortable, there was no intolerance. Conclusion: The cataract surgery pharmacological support in glaucoma patients (including 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) showed: high efficiency (in prevention of infectious and inflammatory complications); safety by influence on the ocular surface; comfort of use.
topic cataract surgery
glaucoma
pharmacological support
ocular surface
0.09 % bromfenac
url https://www.ophthalmojournal.com/opht/article/view/697
work_keys_str_mv AT svyanchenko effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients
AT avmalyshev effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients
AT snsakhnov effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients
AT gyukarapetov effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients
_version_ 1721251080191344640